What does Covid 19 do to patients with long standing Kidney disease and the impact of treatment on their course in hospital - a tertiary care hospital study
Not Applicable
- Conditions
- Health Condition 1: N189- Chronic kidney disease, unspecifiedHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/11/029173
- Lead Sponsor
- Kasturba Medical College Manipal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All Adult patients above 18 yrs of age admitted with COVID and Kidney disease between
30/03/2020 to 30/09/2020.
2. CKD (all Stages with eGFR <60 ml/min/1.73 m2 according to the CKD-EPI Equation)
Newly diagnosed with COVID-19 by RT-PCR or Rapid antigen Test (RAT).
Classification is based on the Kidney Disease Improving Global Outcome
(KDIGO) classification of chronic kidney disease (CKD).
Exclusion Criteria
Patients less than 18 years of age
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Initial presentation and symptomatology <br/ ><br> <br/ ><br>2. Initial laboratory parameters and radiographic findings <br/ ><br> <br/ ><br>3. Course in the hospital from the day of admission.Timepoint: day 1,3,5,7,10, 14, etc., till discharge, DAMA, death
- Secondary Outcome Measures
Name Time Method 1. Impact of interventions and treatments given on disease course including Remdesivir, Corticosteroids, etc. <br/ ><br> <br/ ><br>2. Secondary complications arising during the course of hospital stay including later laboratory parameters and radiographic findings. <br/ ><br> <br/ ><br>3. Final outcomes including recovery till discharge, DAMA or deathTimepoint: day 1,3,5,7,10, 14, etc., till discharge, DAMA, death